Ping Wang
55Patents
8h-index
107Co-inventors
81Inventor score
Filing activity: Feb 22, 1994 → Jun 28, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6120764A | Adenoviruses for control of gene expression | Chemistry; Metallurgy | 39 | Expired |
| US7354740B2 | Animal product free system and process for purifying a botulinum toxin | Chemistry; Metallurgy | 38 | Expired |
| US7160699B2 | Media for clostridium bacterium and processes for obtaining a clostridial toxin | Emerging Cross-Sectional Technologies | 28 | Expired |
| US7560251B2 | Media for Clostridium bacterium | Emerging Cross-Sectional Technologies | 18 | Active |
| US8841110B2 | Animal product free system and process for purifying a botulinum toxin | Chemistry; Metallurgy | 16 | Active |
| US8409828B2 | Animal product free system and process for purifying a botulinum toxin | Chemistry; Metallurgy | 15 | Active |
| US6864237B2 | Treatment of shock using adrenomedullin and adrenomedullin binding protein-1 | Human Necessities | 13 | Expired |
| US6884781B2 | Treatment of shock using adrenomedullin binding protein-1 | Human Necessities | 11 | Expired |
| US9266861B2 | Method of synthesizing thyroid hormone analogs and polymorphs thereof | Emerging Cross-Sectional Technologies | 7 | Active |
| US5492871A | Superstoichiometric MgAl.sub.2 O.sub.4 spinel and use thereof, and process for the synthesis thereof | Chemistry; Metallurgy | 7 | Expired |
| US8012716B2 | Media for clostridium bacterium and processes for obtaining a clostridial toxin | Emerging Cross-Sectional Technologies | 7 | Active |
| US9880776B1 | Content-driven data protection method for multiple storage devices | Physics | 6 | Active |
| US10376517B2 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof | Emerging Cross-Sectional Technologies | 6 | Active |
| US9481724B2 | hDC-sign binding peptides | Human Necessities | 5 | Active |
| US8324151B2 | Treatment of sepsis and septic shock using ghrelin and growth hormone | Human Necessities | 5 | Active |
| US6245813A | Use of ubenimex and the pharmaceutical composition containing it for treating virus hepatitis | Human Necessities | 4 | Expired |
| US9059038B2 | System for in-situ film stack measurement during etching and etch control method | Electricity | 4 | Active |
| US10894050B2 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US5686305A | Establishment of new cell lines from Pseudaletia unipuncta with differential responses to baculovirus | Chemistry; Metallurgy | 4 | Expired |
| US9109023B2 | Treatment of inflammatory diseases by inhibiting cold-inducible RNA-binding protein (CIRP) | Emerging Cross-Sectional Technologies | 3 | Active |
| US11564926B2 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US9489271B1 | User interface for restoring databases | Physics | 2 | Active |
| US8703138B2 | Treatment of inflammatory diseases by inhibiting cold-inducible RNA-binding protein (CIRP) | Emerging Cross-Sectional Technologies | 2 | Active |
| US6187558A | Invertebrate intestinal mucin cDNA and related products and methods | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9957295B2 | Peptides inhibiting cold-inducible RNA binding protein activity | Emerging Cross-Sectional Technologies | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.